Bill > LD238

This bill amends the Maine Medical Use of Marijuana Act to establish new provisions related to the manufacturing of marijuana products and concentrate. Key provisions include: - Defining terms like "inherently hazardous substance," "manufacture or manufacturing," and "marijuana concentrate" to provide more clarity around the manufacturing process. - Authorizing qualifying patients, primary caregivers, and registered dispensaries to manufacture marijuana products and concentrate, with some restrictions on the use of inherently hazardous substances. - Creating a tiered system for registering and regulating manufacturing facilities, including requirements for safety, testing, packaging, and labeling of products. - Allowing municipalities to regulate registered primary caregivers, dispensaries, testing facilities, and manufacturing facilities, though municipalities cannot prohibit or limit the number of registered primary caregivers. - Requiring criminal history record checks for principal officers, board members, and employees of manufacturing facilities using inherently hazardous substances. - Establishing annual registration fees for manufacturing facilities and those authorized to conduct marijuana extraction using inherently hazardous substances. The bill is presented as an emergency measure to provide increased oversight and safety requirements for the manufacturing of medical marijuana products.

Business and Industry, Health and Social Services

http://legislature.maine.gov/legis/bills/display_ps.asp?LD=238&snum=128